caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1477759454

Farhad SafiM.D.

OphthalmologyPort Orange, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Farhad Safi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 6 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Diagnostic Laboratory Services, Inc
Clinical Laboratory · Aiea, HI
42118
Michael Bennett
Ophthalmology · Honolulu, HI
2338
Clinical Laboratories Of Hawaii Llp
Clinical Laboratory · Ewa Beach, HI
2365
Kellen Kashiwa
Optometry · Honolulu, HI
1629
THE QUEEN'S MEDICAL CENTER1225
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Diagnostic Laboratory Services, Inc
Clinical Laboratory · Aiea, HI
4093
Clinical Laboratories Of Hawaii Llp
Clinical Laboratory · Ewa Beach, HI
2382
OTTO, CLIFTON2253
Kellen Kashiwa
Optometry · Honolulu, HI
1727
Wendell Danforth
Ophthalmology · Kapolei, HI
1428
THE QUEEN'S MEDICAL CENTER1227
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
4,634
Unique beneficiaries
—
Total services
83,848
Distinct HCPCS
21
Medicare payment
$4.0M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,263 Ophthalmology providers in FL — top quintile (cohort median 2,598).
PRESCRIBING · PART D · 2024
Total Rx claims
1,538
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
15
Brand share
52.9%
Top prescribed drugs
Ketorolac Tromethamine350 claims
Aflibercept342 claims
Faricimab-Svoa277 claims
Prednisolone Acetate212 claims
Moxifloxacin Hcl66 claims
QUALITY · MIPS · 2024
Final MIPS score
99.7
Quality
99.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.04%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$891
Payment records
29
By payment type
Food and Beverage$891